Skip to main content
. 2023 Oct 26;18(1):59. doi: 10.5334/gh.1262

Table 2.

Treatment of Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM).


TREATMENT OF ATTR-CM: SUMMARY KEY POINTS

  • Treatment of cardiovascular symptoms, complications and comorbidities


          Heart failure

          Arrhythmias

          Thromboembolism

          Orthostatic hypotension

          Correction of aortic stenosis and other valvular defects (if indicated)

          Heart transplantation/other measures for advanced heart failure

  • Specific treatments


          Transthyretin stabilizers

          Transthyretin silencers

          Other (possible non-genetic and genetic therapies)

  • Supportive therapeutic measures


          Exercise & Nutrition

          Vaccines

          Individualized approach to physical and emotional patient’s needs